Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New "drugs and targets" in the GWAS era of bipolar disorder.

Bipolar disorders - 1 Aug 2023

Qi Hao-Xiang, Xiao Xiao, Li Tao, Li Ming

Abstract excerpt

OBJECTIVE: Due to the phenotypic heterogeneity and etiological complexity of bipolar disorder (BD), many patients do not respond well to the current medications, and developing novel effective treatment is necessary. Whether any BD genome-wide association study (GWAS) risk genes were targets of existing drugs or novel drugs that can be repurposed in the clinical treatment of BD is a hot topic in the GWAS era of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Bipolar Disorder
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Phenotype

Source

Identifiers

PMID: 36633396
DOI: 10.1111/bdi.13295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New "drugs and targets" in the GWAS era of bipolar disorder.PMID 36633396Read ↗

Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings.Semantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Identification of bipolar disorder related biomarkers, signaling pathways and potential therapeutic compounds based on bioinformatics methods and molecular docking technologySemantic proximity Read ↗

Genetics of bipolar disorder: Translating discoveries to biological insights and clinical decision support.Semantic proximity Read ↗

Integrative analysis of transcriptome-wide association study and mRNA expression profile identified risk genes for bipolar disorder.Semantic proximity Read ↗

Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.Semantic proximity Read ↗

Pharmacogenomic aspects of bipolar disorder: An updateSemantic proximity Read ↗

Genetics of bipolar disorder: insights into its complex architecture and biology from common and rare variants.Semantic proximity Read ↗

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selectionSemantic proximity Read ↗

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disordersSemantic proximity Read ↗

Identification of molecular signatures and pathways common to blood cells and brain tissue based RNA-Seq datasets of bipolar disorder: Insights from comprehensive bioinformatics approachSemantic proximity Read ↗

Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.